Quellen

Trilles B et al., Flavour and Fragrance Journal 2006 (Chemotypen von Melaleuca quinquenervia). Ramanoelina PAR et al., Main Industrial Niaouli Oil Chemotype Productions from Madagascar (ResearchGate 236122770). Ireland BF, Hibbert DB, Goldsack RJ, Doran JC, Brophy JJ, Chemical variation in the leaf essential oil of Melaleuca quinquenervia, Biochemical Systematics and Ecology 2002. Juergens UR, Anti-inflammatory properties of the monoterpene 1,8-cineole, Drug Research 2014 (PubMed 24831245). Review PMC7467491, New Perspectives for Mucolytic, Anti-inflammatory and Adjunctive Therapy with 1,8-Cineole in COPD and Asthma. Kehrl W, Sonnemann U, Dethlefsen U, Therapy for acute nonpurulent rhinosinusitis with cineole, Laryngoscope 2004. Fischer J, Dethlefsen U, Efficacy of cineole in patients suffering from acute bronchitis, Cough 2013. Clinical Phytoscience 2021, Cineole Phase-III-Studie zu Soledum, DOI 10.1186/s40816-021-00319-8.

Pharmakologischer Cineol-Review, ScienceDirect PII S0753332223012659. J. Soc. Cosmet. Sci. Korea, MHK-Werte des Blattextrakts gegen Hautkeime (koreascience.kr/article/JAKO201431454589024). Braz. Arch. Biol. Technol., In Vitro and in Silico Assessment of Niaouli Essential Oil (Biofilm und Quorum Sensing bei P. aeruginosa). Chemical Composition and Antibacterial Activity of Essential Oil of Melaleuca quinquenervia, ResearchGate 377721776. Antivirale Aktivitaet, Astani et al., Evidence-Based Complementary and Alternative Medicine 2011, Article nep187; Uebersicht Schnitzler et al. Plants of the Melaleuca Genus as Antimicrobial Agents Review, PubMed 28782167. Anti-inflammatory Properties of Melaleuca Quinquenervia Leaves Essential Oil, J. Chem. Pharm. Res. (jocpr.com). Serafino A et al., Essential oil of niaouli preferentially potentiates antigen-specific cellular immunity, PubMed 18668393.

EJOH 2022, Anti-proliferative Effect of Niaouli and Elemi Essential Oils on Cell Lines. Phytomedicine, Anti-Melanogenese-Studie in B16-Zellen, ScienceDirect S0944711317301137. Nanoemulsification Improves the Pharmaceutical Properties and Bioactivities of Niaouli Essential Oil, Molecules 2021, PMC8401722. Karger, Schweizerische Zeitschrift fuer Ganzheitsmedizin 2016, DOI 10.1159/000452783 (Beobachtungsstudie Strahlentherapie). MASCC Clinical Practice Guideline Radiation Dermatitis 2023, Lancet eClinicalMedicine. DrugBank-Eintrag DB16618, Niaouli Oil. Tisserand R, Young R, Essential Oil Safety, 2. Auflage (Standardreferenz zur Sicherheit). International Federation of Aromatherapists, Contraindication Guidelines (ifaroma.org). PMC9323951, Placental Toxicity of Essential Oils. PMC4014229, Acute and subacute toxicity of 1,8-cineole; PubMed 27644596, Repeated-dose and reproductive toxicity.

DermNet NZ, Allergic contact dermatitis to essential oils; Barbaud A et al., Contact Dermatitis 2023, DOI 10.1111/cod.14377. Aromatherapeutische Praxis- und Uebersichtstexte: Aroma-Zone, Essenciagua, AromaWeb, New Directions Aromatics, Quinessence, Baseformula, Aromapraxis, Thieme Natuerlich Medizin, aroma1x1, Boemia Aroma, Soin-et-Nature, Native Oils Australia (Nerolina), Essential Oils Pedia, Ölerini, WebMD Monographie Niaouli oil.